PL4072533T3 - Postać dawkowania zawierająca środek zasadowy i warstwę powłoki dojelitowej - Google Patents

Postać dawkowania zawierająca środek zasadowy i warstwę powłoki dojelitowej

Info

Publication number
PL4072533T3
PL4072533T3 PL20780967.4T PL20780967T PL4072533T3 PL 4072533 T3 PL4072533 T3 PL 4072533T3 PL 20780967 T PL20780967 T PL 20780967T PL 4072533 T3 PL4072533 T3 PL 4072533T3
Authority
PL
Poland
Prior art keywords
coating layer
dosage form
enteric coating
alkaline agent
form containing
Prior art date
Application number
PL20780967.4T
Other languages
English (en)
Inventor
Priyanka HAKSAR
Shraddha Joshi
Umesh KAPALE
Nilam BHARAMBE
Ashish Guha
Vinay JAIN
Original Assignee
Evonik Operations Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Operations Gmbh filed Critical Evonik Operations Gmbh
Publication of PL4072533T3 publication Critical patent/PL4072533T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2813Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/501Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL20780967.4T 2019-12-11 2020-09-17 Postać dawkowania zawierająca środek zasadowy i warstwę powłoki dojelitowej PL4072533T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201941051238 2019-12-11
PCT/EP2020/075960 WO2021115648A1 (en) 2019-12-11 2020-09-17 Dosage form comprising an alkaline agent and an enteric coating layer

Publications (1)

Publication Number Publication Date
PL4072533T3 true PL4072533T3 (pl) 2025-06-16

Family

ID=72659788

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20780967.4T PL4072533T3 (pl) 2019-12-11 2020-09-17 Postać dawkowania zawierająca środek zasadowy i warstwę powłoki dojelitowej

Country Status (14)

Country Link
US (1) US20230000780A1 (pl)
EP (1) EP4072533B1 (pl)
JP (1) JP7754812B2 (pl)
KR (1) KR20220113697A (pl)
CN (1) CN114828833A (pl)
BR (1) BR112022011130A2 (pl)
CA (1) CA3160876A1 (pl)
ES (1) ES3023309T3 (pl)
HU (1) HUE070718T2 (pl)
IL (1) IL293651B1 (pl)
MX (1) MX2022007162A (pl)
PL (1) PL4072533T3 (pl)
SI (1) SI4072533T1 (pl)
WO (1) WO2021115648A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102938078B1 (ko) 2019-05-15 2026-03-11 에보닉 오퍼레이션스 게엠베하 캡슐 충전 기계를 사용한 셀룰로오스 또는 전분을 기반으로 하는 코팅을 갖는 충전된 경질 쉘 캡슐의 제조 방법
CA3160869C (en) 2019-12-11 2024-06-25 Priyanka HAKSAR Dosage form for use in treating or preventing of a disease
WO2023137556A1 (en) * 2022-01-20 2023-07-27 Bionxt Solutions Inc. Chemical composition for enteric drug delivery
WO2023174722A1 (en) 2022-03-15 2023-09-21 Evonik Operations Gmbh Pre-functionalized hard shell capsule with accelerated drug release at ph value 5 to 5.5
EP4518841B1 (en) * 2022-05-06 2025-12-17 Evonik Operations GmbH Dosage form with drug release at ph 3 to 6 using double coating system with at least one release acceleration agent

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
US6500457B1 (en) * 2000-08-14 2002-12-31 Peirce Management, Llc Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
EP1677770A2 (en) * 2003-10-31 2006-07-12 Dexcel Ltd. Stable lansoprazole formulation
CA2558535A1 (en) 2004-03-03 2005-10-06 Teva Pharmaceutical Industries Ltd. A stable pharmaceutical composition comprising an acid labile drug
DE102005032806A1 (de) 2005-07-12 2007-01-18 Röhm Gmbh Verwendung eines teilneutralisierten, anionischen (Meth)acrylat-Copolymers als Überzug für die Herstellung einer Arzneiform mit einer Wirkstofffreisetzung bei erniedrigten pH-Werten
DE102006035549A1 (de) 2006-07-27 2008-01-31 Evonik Röhm Gmbh Arzneiform mit mindestens zweischichtiger Trennschicht
DK2152250T3 (da) 2007-05-07 2019-12-09 Evonik Degussa Gmbh Faste doseringsformer, der omfatter et enterisk overtræk, med accelereret lægemiddelfrigivelse
AU2008282900B2 (en) * 2007-07-27 2014-05-22 Depomed, Inc. Pulsatile gastric retentive dosage forms
CN102626398A (zh) * 2012-04-18 2012-08-08 上海腾瑞制药有限公司 一种泮托拉唑钠肠溶片及其制备方法
PL2871973T3 (pl) * 2012-07-12 2019-02-28 Novus International Inc. Kompozycje matrycy i warstwy do ochrony środków bioaktywnych
CA2910865C (en) * 2014-07-15 2016-11-29 Isa Odidi Compositions and methods for reducing overdose
CN105640915A (zh) * 2016-03-02 2016-06-08 吉林修正药业新药开发有限公司 一种雷贝拉唑钠肠溶片及其制备工艺
IL293653B1 (en) * 2019-12-11 2026-01-01 Evonik Operations Gmbh A dosage form for use in therapy comprising a core, an intermediate layer, and an enteric coating in a defined ratio
CA3160869C (en) * 2019-12-11 2024-06-25 Priyanka HAKSAR Dosage form for use in treating or preventing of a disease

Also Published As

Publication number Publication date
CN114828833A (zh) 2022-07-29
JP7754812B2 (ja) 2025-10-15
JP2023505714A (ja) 2023-02-10
EP4072533A1 (en) 2022-10-19
EP4072533B1 (en) 2025-01-22
IL293651A (en) 2022-08-01
CA3160876A1 (en) 2021-06-17
IL293651B1 (en) 2026-01-01
WO2021115648A1 (en) 2021-06-17
MX2022007162A (es) 2022-07-12
HUE070718T2 (hu) 2025-06-28
US20230000780A1 (en) 2023-01-05
SI4072533T1 (sl) 2025-04-30
ES3023309T3 (en) 2025-05-30
BR112022011130A2 (pt) 2022-08-23
KR20220113697A (ko) 2022-08-16

Similar Documents

Publication Publication Date Title
PL4072533T3 (pl) Postać dawkowania zawierająca środek zasadowy i warstwę powłoki dojelitowej
LT3999506T (lt) Parp1 inhibitoriai
IL286248A (en) Tyk2 inhibitors and uses thereof
IL284799A (en) Tyk2 inhibitors and uses thereof
EP3978244A4 (en) MULTILAYER FILM AND USE THEREOF
EP3969526A4 (en) COATING COMPOSITION AND ITS USES
DK3567085T3 (da) Coatingsammensætning og coatingfilm dannet deraf
PL3571251T3 (pl) Kompozycja powłokowa zapobiegająca porastaniu, podłoże powleczone taką kompozycją powłokową oraz zastosowanie takiej kompozycji powłokowej
PL3939232T3 (pl) Łagodzenie skutków ataków komputerowych
SG11202004174YA (en) Foul release coating composition, substrate coated with such coating composition, and use of such coating composition
EP3756885A4 (en) MULTI-LAYER FILM WITH GLARE PROTECTION HARD COATING
EP4365250A4 (en) Migration-preventing coating agent
EP4119620A4 (en) Antifouling coating composition
EP3932407C0 (en) ENTERIC COATED TABLET COMPOSITION COMPRISING TETRAMETHYLPYRAZINE NITRONE
EP3689977A4 (en) COATING COMPOSITION AND COATING FILM
EP3981596A4 (en) COATING COMPOUNDS AND COATINGS
EP3950865A4 (en) COATING COMPOSITION
EP3913022A4 (en) ANCHOR COATING AGENT
EP3903947A4 (en) Paste coating device
PL3834936T3 (pl) Urządzenie i sposób powlekania podłoży warstwami pośrednimi
EP3877437C0 (en) COATING COMPOSITION
IL289640A (en) Antibodies binding igc2 of igsf11 (vsig3) and uses thereof
EP3474824A4 (en) GOOD SUCKABLE COATINGS AND SUBSTRATES COATED WITH THESE
EP3950862A4 (en) COATING COMPOSITION AND COATING FILM
EP3977880C0 (en) COAT